“…However, in the present study, there was a mixed population in the SITA graft group, which included LITA plus RA with or without saphenous vein (SVG) in 80% of the patients and LITA plus SVG in the remaining patients. 2 Therefore, we are concerned about the difference of outcomes between the BITA and SITA graft groups was derived from these 20% of patients with LITA plus SVG. If the authors can provide an additional subgroup analysis, it would have better clarified the significance of their findings.…”